Keyphrases
Lynch Syndrome
100%
Colorectal Cancer
76%
MLH1
61%
Tumor
40%
Software Factory
38%
Lynch-like
38%
Management Model
38%
Peru
33%
Spanish Population
33%
Germ Cells
31%
Colorectal Cancer Risk
30%
TGFBR1
28%
Tumor Cells
25%
Colorectal Cancer Patients
24%
Hereditary Colorectal Cancer Syndromes
23%
Germline mutation
21%
Molecular Characterization
21%
Methylation Analysis
21%
Cancer Risk
20%
Epimutation
20%
Risk Factors
20%
Peruvian
19%
First-degree Relatives
19%
Computer Science Education
19%
Spanish-speaking Patients
19%
Clinical Characterization
19%
Non-muscle Invasive Bladder Cancer (NMIBC)
19%
Multimarker
19%
Cancer Prognosis
19%
Internet of Things
19%
Productivity Factors
19%
Social Networks
19%
Arbitrary PCR
19%
Ultrasound
19%
Comprehensive Management
19%
Enterprise Content Management
19%
Mismatch Repair Genes
19%
Methylation
18%
Blood Samples
18%
MLH1 Methylation
17%
Genetic Variants
17%
SNP
17%
Cancer Patients
16%
Small to Medium Size Enterprises
15%
MSH6
15%
DNA Methylation (DNAm)
14%
Circulating Tumor Cells
14%
Environmental Levels
14%
Heritability
14%
Spain
13%
Missense
13%
Allele-specific Expression
13%
Confidence Interval
13%
Public Universities
12%
Primary Tumor
12%
DNA Fingerprinting
12%
Desertion
12%
Dropout
12%
Microfluidic Device
12%
Genome Analysis
12%
Epithelial Cell Adhesion Molecule (EpCAM)
11%
Penetrance
11%
Genetic Characterization
11%
Formalin-fixed Paraffin-embedded Tissue
11%
Pathogenic Variants
11%
White Blood Cells
11%
Non-associated
11%
PMS2
11%
Clinical Genetics
10%
Renal Cancer
10%
Molecular Characteristics
10%
Tumor Progression
10%
Patients with Colorectal Cancer
10%
Clinical Practice Guidelines
10%
Colorectum
10%
Bladder Cancer Risk
10%
Gastrointestinal
10%
Genetic Testing
10%
Patient Selection
10%
Polymorphic Variants
10%
Cancer Syndromes
10%
Serrated Polyposis Syndrome
10%
Polyps
10%
Microsatellite Instability-high (MSI-H)
10%
Polymorphism
10%
Information Science Education
9%
Learning Process
9%
Undergraduate Computer Science
9%
Pathological Characterization
9%
Computer Science
9%
Bayesian Assessment
9%
Waiting Time
9%
Wavelet
9%
Student Perspectives
9%
Methylation-sensitive Amplification Polymorphism
9%
Methylation-sensitive AFLP
9%
Effective Alternative
9%
DNA Methylation Analysis
9%
Human Cancer
9%
Evaluation Model
9%
Biochemistry, Genetics and Molecular Biology
MLH1
72%
DNA Mismatch Repair
47%
Methylation
41%
Germ Cell
40%
Genetics
39%
Germline
31%
Prevalence
30%
Epimutation
28%
Allele
27%
Penetrance
26%
MSH2
25%
Next Generation Sequencing
23%
Genetic Divergence
23%
Case-Control Study
23%
MSH6
22%
Microsatellite Instability
21%
Germline Mutation
21%
Gene Repair
20%
Single Nucleotide Polymorphism
19%
DNA Methylation
19%
Haplotype
18%
Tumor Progression
16%
Transforming Growth Factor Beta
15%
PMS2
14%
Missense
14%
Epigenetics
13%
Genetic Screening
12%
Gene Mutation
11%
Karyotype
11%
Signal Transduction
11%
DNA Profiling
11%
Colon
9%
Single-Nucleotide Polymorphism
9%
Mosaicism
9%
Mir-143
9%
Mucosa
9%
Risk Reduction
9%
Cohort Study
9%
Cancer Cell
9%
Clinical Classification
9%
Molecular Genetics
9%
Transcription
9%
Exome
9%
RNA Polymerase III
9%
Metagenomics
9%
Exome Sequencing
9%
Microbiome
9%
Amplified Fragment Length Polymorphism
9%
Mir-145
9%
MicroRNA
9%
B Cell
9%
Comparative Genomic Hybridization
9%
MUTYH
9%
Microsatellite
9%
Normal Human
9%
Exon
8%
Protein Expression
8%
Population Dynamics
7%
Proband
7%
Multiplex Ligation-Dependent Probe Amplification
6%
Tumor Gene
6%
Oncogene
6%
Cancer Staging
6%
Real-Time Polymerase Chain Reaction
6%
Fluorescence in Situ Hybridization
5%
Autosomal Dominant Inheritance
5%
Promoter Region
5%
Genomics
5%